5KK3

Atomic Resolution Structure of Monomorphic AB42 Amyloid Fibrils

5KK3 の概要

• エントリーDOI: 10.2210/pdb5kk3/pdb
• NMR情報: BMRB: 30121
• 分子名称: Beta-amyloid protein 42 (1 entity in total)
• 機能のキーワード: amyloid beta, fibril, protein fibril
• 由来する生物種: Homo sapiens (Human)
• タンパク質・核酸の鎖数: 18
• 化学式量合計: 81361.57

構造登録者

Colvin, M.T.,Silvers, R.,Zhe Ni, Q.,Can, T.V.,Sergeyev, I.,Rosay, M.,Donovan, K.J.,Michael, B.,Wall, J.,Linse, S.,Griffin, R.G. (登録日: 2016-06-20, 公開日: 2016-07-13, 最終更新日: 2024-05-01)

主引用文献

Colvin, M.T.,Silvers, R.,Ni, Q.Z.,Can, T.V.,Sergeyev, I.,Rosay, M.,Donovan, K.J.,Michael, B.,Wall, J.,Linse, S.,Griffin, R.G.
Atomic Resolution Structure of Monomorphic A beta 42 Amyloid Fibrils.
J.Am.Chem.Soc., 138:9663-9674, 2016

PubMed Abstract: Amyloid-β (Aβ) is a 39-42 residue protein produced by the cleavage of the amyloid precursor protein (APP), which subsequently aggregates to form cross-β amyloid fibrils that are a hallmark of Alzheimer's disease (AD). The most prominent forms of Aβ are Aβ1-40 and Aβ1-42, which differ by two amino acids (I and A) at the C-terminus. However, Aβ42 is more neurotoxic and essential to the etiology of AD. Here, we present an atomic resolution structure of a monomorphic form of AβM01-42 amyloid fibrils derived from over 500 (13)C-(13)C, (13)C-(15)N distance and backbone angle structural constraints obtained from high field magic angle spinning NMR spectra. The structure (PDB ID: 5KK3 ) shows that the fibril core consists of a dimer of Aβ42 molecules, each containing four β-strands in a S-shaped amyloid fold, and arranged in a manner that generates two hydrophobic cores that are capped at the end of the chain by a salt bridge. The outer surface of the monomers presents hydrophilic side chains to the solvent. The interface between the monomers of the dimer shows clear contacts between M35 of one molecule and L17 and Q15 of the second. Intermolecular (13)C-(15)N constraints demonstrate that the amyloid fibrils are parallel in register. The RMSD of the backbone structure (Q15-A42) is 0.71 ± 0.12 Å and of all heavy atoms is 1.07 ± 0.08 Å. The structure provides a point of departure for the design of drugs that bind to the fibril surface and therefore interfere with secondary nucleation and for other therapeutic approaches to mitigate Aβ42 aggregation.

PubMed: 27355699
DOI: 10.1021/jacs.6b05129

実験手法

SOLID-STATE NMR